Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The United Kingdom Thalassaemia Society (UKTS) is a national charity and company limited by guarantee dedicated to supporting individuals affected by thalassaemia, a group of inherited blood disorders. Founded in 1976, the organization provides essential support services, including patient advocacy, educational resources, and counseling for patients and their families. UKTS works closely with healthcare professionals and the National Health Service (NHS) to develop clinical standards and improve the management of the condition across the UK. Additionally, the society funds medical research aimed at improving treatment outcomes and finding a permanent cure for thalassaemia. Through its awareness campaigns and annual conferences, UKTS remains the leading authority for thalassaemia support and information in the United Kingdom.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on United Kingdom Thalassaemia Society.